Aclarion (ACON) Capital Expenditures (2024 - 2025)
Aclarion (ACON) posted Capital Expenditures of $13726.0 for Q4 2025, up 87.49% on a QoQ basis from $7321.0 in Q3 2025, and up 168.35% year-over-year from $5115.0 in Q4 2024.
Aclarion (ACON) Capital Expenditures (2024 - 2025) Analysis & Trends
Aclarion's Capital Expenditures history runs 2 years deep, the most recent figure standing at $13726.0 for Q4 2025.
- Quarterly Capital Expenditures rose 168.35% year-over-year to $13726.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26162.0 (changed N/A YoY) and the FY2025 annual result came in at $21528.0, up 320.88% from the prior year.
- Capital Expenditures was $13726.0 for Q4 2025 at Aclarion, up from $7321.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $13726.0 in Q4 2025 and bottomed at $5115.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 1.75 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 21.54 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 83,000.00 |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 118,000.00 |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 56.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 15.33 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | -6.65 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | -978,000.00 |
| 10 | Aclarion | 4.73 Mn | 4.73 Mn | 3,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,726.00 |
| Dec 31, 2025 | 13,726.00 |
| Sep 30, 2025 | 7,321.00 |
| Sep 30, 2025 | 7,321.00 |
| Dec 31, 2024 | 5,115.00 |
| Dec 31, 2024 | 5,115.00 |